Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease
NCT04284878 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2020-02-26
Summary
This study aims:
1. To investigate the association between single nucleotide polymorphisms of PTPN22 gene (rs2476601, rs33996649 and rs2488457) and inflammatory bowel disease.
2. To correlate the relation between the studied SNPs and disease activity /response to therapy.
Conditions
- Inflammatory Bowel Diseases
Interventions
- GENETIC
-
PCR-RFLP
PCR-Restriction fragment length polymorphism
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2021-05-31
- Completion
- 2021-09-30
More Related Trials
-
Genetic Studies of Inflammatory Bowel Disease
NCT00340444 ·Status: COMPLETED
-
Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease
NCT04286659 ·Status: UNKNOWN
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
NCT06935942 ·Status: COMPLETED
-
Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
NCT07181525 ·Status: RECRUITING
-
Coagulation Parameters in IBD Patients
NCT04115722 ·Status: UNKNOWN
-
An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients
NCT06961435 ·Status: COMPLETED
-
Impact of Different Dietary IgGs on the Pathogenesis of IBD
NCT03885479 ·Status: UNKNOWN
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF
NCT01605175 ·Status: COMPLETED
-
Characterization of Phenotype and Genotype of Early Onset Enteropathies
NCT02614911 ·Status: RECRUITING
-
Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2011).
NCT02392221 ·Status: COMPLETED
-
Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort
NCT02502552 ·Status: COMPLETED
-
Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE
NCT03788824 ·Status: UNKNOWN
-
Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease
NCT02181153 ·Status: COMPLETED ·Phase: NA
-
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
NCT02255227 ·Status: TERMINATED ·Phase: PHASE2
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN
-
Platelet Indices in Inflammatory Bowel Diseases
NCT07320443 ·Status: NOT_YET_RECRUITING
-
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
NCT06995170 ·Status: RECRUITING
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387 ·Status: RECRUITING
-
Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease
NCT02847052 ·Status: TERMINATED
-
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
NCT00586599 ·Status: COMPLETED ·Phase: NA
-
Pre-genotype NUDT 15 R139C on Reducing Thiopurine-induced Leucopenia in Inflammatory Bowel Disease
NCT02929706 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease
NCT04882566 ·Status: UNKNOWN